Results 211 to 220 of about 53,470 (300)

Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy. [PDF]

Clinicoecon Outcomes Res
Di Matteo S, Bonanni P, Boccalini S, Di Virgilio R, Fogliati EL, Colombo GL.   +5 more
europepmc   +1 more source

neonSoilFlux: An R package for continuous sensor‐based estimation of soil CO2 fluxes

Methods in Ecology and Evolution, EarlyView.
Abstract Accurate quantification of soil carbon fluxes is essential to reduce uncertainty in estimates of the terrestrial carbon sink. However, these fluxes vary over time and across ecosystem types and so, it can be difficult to estimate them accurately across large scales.
John Zobitz, Edward Ayres, Zoey Werbin, Ridwan Abdi, Natalie Ashburner‐Wright, Lillian Brown, Ryan Frink‐Sobierajski, Lajntxiag Lee, Dijonë Mehmeti, Christina Tran, Ly Xiong, Naupaka Zimmerman   +11 more
wiley   +1 more source

QALYs or short straws

BMJ, 1986
openaire   +5 more sources

The broad societal value of pembrolizumab for women's cancer in Canada. [PDF]

Future Oncol
Brook E, Patterson K, Wijenayake N, Madin-Warburton M, Mishkin K, Meilleur MC, Davies A, Young K.   +7 more
europepmc   +1 more source

Cost‐effectiveness of in‐hospital motivational smoking cessation counselling and proactive referral to community‐based follow‐up

Addiction, EarlyView.
Abstract Background and aim In a randomised open‐label trial among hospitalised patients with atherosclerotic vascular disease, motivational smoking cessation counselling with proactive referral to community‐based follow‐up was more effective than brief cessation advice and written information, with 6‐month continuous abstinence rates of 49.5% vs. 24.5%
Karin Pleym, Ingrid Engebretsen, Elise Sverre, Toril Dammen, Einar Huseby, Mohpal Singh Kahlon, Marie Stugaard, Henrik Støvring, Ivar Sønbø Kristiansen, John Munkhaugen   +9 more
wiley   +1 more source

Cost-utility analysis of traditional Korean medicine without acupuncture claims versus integrative care for menopausal disorders: A nationwide retrospective cohort study. [PDF]

Integr Med Res
Lee JY, Kim JU, Bae KH, Lee S, Park MY.
europepmc   +1 more source

Health and economic impact of universal screening and management of alcohol use disorders in India: An economic modelling study

Addiction, EarlyView.
Abstract Aim The study assessed the health and economic implications as well as the cost‐utility of implementing universal alcohol use disorder (AUD) screening in 15–74 years population at the primary healthcare level compared with the current practice of diagnosis and management of symptomatic AUD patients seeking formal healthcare. Design Model‐based
Neha Purohit, Shubhmohan Singh, Atul Ambekar, Ajay Duseja, Ashwani Kumar Mishra, Girish N. Rao, Kathirvel Soundappan, Atul Kotwal, Shankar Prinja   +8 more
wiley   +1 more source

Targeted Systemic Therapies for Atopic Dermatitis in Australia: A Narrative Review

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease estimated to affect approximately 30% of children and 10%–15% of adults in Australia. Of those with this condition, one in five is estimated to have moderate‐to‐severe disease.
Diana Rubel, Peter Foley, Kathryn A. Gibson, Anita Townsend, Gabrielle Louise Reppen, William Romero Gallardo   +5 more
wiley   +1 more source

Erratum: Cost-Effectiveness of an Absorbable Antibacterial Envelope for Infection Control in Cardiac Implantable Electronic Device Procedures in Spain. [PDF]

J Health Econ Outcomes Res
Datino T, Afonso D, Greaves E, Eggington S, Monje J, Álvarez Orozco M, Wolff C, Mealing S, de Alarcón A.   +8 more
europepmc   +1 more source

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim, Jacqueline Tu, Kelvin Truong, Gloria Fong, William Luu, Peter Barclay, Melanie Wong, Li‐Chuen Wong   +7 more
wiley   +1 more source